Login   Contact Us      

Improve Your Reimbursement Results

Serum versus Plasma

Take Control of Your Medicare A/R

Staff Feedback Pays Dividends

Boost Cash Flow by Tracking DSO

Pharmacy Quality Standards

Billing Specialists Get The Job Done

Should you Part D

The Right Team Makes A Great Company

The Importance of Proper Aseptic Technique

The Answers Are in Your Data

Synercid

Inside the 835 - Part 1 - CR Codes

Treating an Unhealthy Accounts Receivable

Are You Compounding or Manufacturing?

Prepare For Bad Debt Reserves

Maximizing Your Value in Mergers and Acquisitions

Is Outsourcing Right For You?

Team Talent is Essential

What's the Value of Your Business

Inside the 835: Part 2--Medicare Codes

Pharmacists Recognized As A Provider:

Part D Success Story: $24K Denied, Then Reversed

Maximize Revenue On Rental Equipment

Leverage Points: Mission and Vision

The Value of Therapeutic Drug Monitoring

Listserv Lessons: Post-dose Vancomycin peak draws

Take Control of Your Patient Receivables

Acquisition Strategy – Securing Management

Pedigree Provisions: A New Responsibility

Cash is still King

Listserv Lessons: Patient Financial Responsibility

HEMOLYSIS - CAUSE AND EFFECT

Who's tracking YOUR sales?

Five Approaches to Training a Sales Person

CASH FLOW: Shows Your Company’s True Health

NPI Deadline is May 23 - Are you ready?

Listserv Lessons: Billing Per Diems on Non-Infused

Microalbumin

Credit Balances, an overlooked problem

Managing Open Invoices

Listserv Lessons: Insurance Company defining AWP

Revenue Recognition: Are You Collecting 95%?

BitLeap's online, offsite data backup system

Is NHIC getting The Job Done?

Drug of the Month - Infliximab

Sed.Rate and C-Reative Protein Assay

A Systemic Approach to Purchasing Negotiations

A Systemic Approach to Purchasing Negotiations 2

Practical Approach to Physician Credentialing

Is Noridian Getting The Job Done?

The Pharmacist’s Awareness of “Drug Induced Diseas

Listserv Lessons: Medicare Billing Split between M

Glycosylated Hemoglobin

Drug of the Month – Daptomycin (Cubicin®)

Using Denial Tracking to Improve Cash Flow and Sta

Dealing with Denial Code 204 (Replacment for PR 96

The Medicare Program: A Brief Overview

ListServ Lessons: Power PICC Flushing Protocols

Can a blood test predict a heart attack?

Software Implementations - do it perfect the first

Drug of the Month – Lynezolid (Zyvox®)

Add a second monitor to your laptop / desktop

Software implementations – it’s a great time to be

Extreme Drug-Resistant Tuberculosis

Listserv Lessons: Home Infusion Pharmacy vs Specia

Patient Satisfaction Scores

Managing your payer pricing files

Leadership: An Analysis

Listserv Lessons: Enteral Practice Standards

MRSA on the Rise

Using Clinicians to Improve Reimbursement

Software Implementations: Multi-site conversions

System Management: Managing Serialized Inventory

So, you have a payer contract…or do you?

Questions and Answers about Lyme Disease

Listserv Lessons: Timely Filing and Patient Debt O

System Implementation: 5 Phases of Information Sy

Managing your Windows Desktop

Insurance Companies Play to Win ... you should too

Blood Culture Contamination

KVO’s on Intermittent Pump Infusions

So, the nice lady at Medicare told you that it wou

Listserv Lessons: Huber Needle Changes

ListServ Lessons: Compounding Question

How many billers necessary to change a light bulb?

Listserv Lessons: Monitoring Shipping

Use of Routine ABNs

Investigating Reimbursement Issues

Repackaging your managed care strategy

Managing your Shared Contract Files

Stale A/R on Legacy Systems – Is It Really Worth I

ListServ Lessons - Infusion of Specialty Meds

Know Who Your Patients Are and Where They Are Comi

Know who your patients are and where they are comi

Patient Pay Accounts - If you can't measure it, yo

Those Pesky Rascals

The Care and Feeding of Your Item Master File

Billing Staff Measurement and Feedback

This Call May be Monitored for Quality Assurance

The Price is Right…Or Maybe Not

Using Time & Motion Studies to Improve Pharmacy Pr

Maximizing Your Value in Mergers and Acquisitions

By Julie Decker
Wednesday, September 13, 2006

Maximizing Your Value in Mergers and Acquisitions
By Julie Decker and Nishen Radia, FocalPoint Partners, LLC

Not since the 1990's has there been such a surge of buyouts and merger activity among home infusion providers.

Currently, this activity makes selling your company sound economic sense.  In today's market, buyers enjoy the benefits of consolidation, economies of scale and entry into new markets, which enables them to offer sellers high valuations. However the myriad of legal issues--financing considerations, and differences in corporate cultures—means that the process needs careful management, experience, and expertise to ensure a successful outcome. Over the next several months, we will address many of the issues that are most critical when planning to sell or recapitalize a company. Whether it is how to maximize the value you receive for your company or how to manage in the run up to a sale, the questions we will answer are questions that every healthcare entrepreneur should be asking. 

In the October issue of Rock-Solid Intelligence we will discuss the specific variables and several ways in which to value a company, either as a seller or a buyer. We will talk about ways to position a company to highlight its strengths and achieve valuations that exceed the industry “standards” that people often refer to.

Since company earnings and cash flow are a major component in any method of valuation, accounts receivables and collections management are critical during an acquisition or merger. In the November issue we will discuss how to maximize these and how the collections process may influence a sale.

Even the most successful sale may result in suboptimal profits if tax planning has not been adequately considered. This will be the topic discussed in December.

Although financial considerations are usually the main drivers of the M & A process, issues such as compatibility of corporate cultures, succession planning and employee retention may ultimately determine the success or failure of a merger. These issues will be addressed in Rock Solid intelligence in 2007.

We look forward to sharing our knowledge and experience with you in the coming months and to help you capitalize on this attractive time in the market cycle.  


Download Article

Julie Decker


Julie Decker is a Strategic Operating Partner at FocalPoint, LLC. She has been a senior level healthcare executive for the past 10 years and the scope of her experience includes national sales responsibility, operations, company turnarounds, and mergers and acquisitions for leading healthcare companies.

View all articles by Julie Decker


FocalPoint Partners, LLC


FocalPoint Partners LLC is an independent investment bank, specializing in mergers and acquisitions (both healthy and distressed), private placements (both debt and equity), and financial restructurings. The firm’s primary focus is on middle-market companies with revenues between $10 million and $250 million in a diverse range of industries. The firm’s goal is to provide unbiased, innovative financial advice by taking the time to truly understand the needs of its clients and then devising a strategy that best fits those objectives.

View all articles by FocalPoint Partners, LLC

 
 


Copyright © 2010 Rock-Pond Solutions. All Rights Reserved.